BioNTech to present clinical data updates on personalized mRNA-based and targeted oncology therapies at AACR 2024.
BioNTech to showcase clinical data updates for personalized mRNA-based and targeted oncology candidates at AACR 2024. BioNTech, a leading mRNA therapy company, will present updates and advancements in personalized cancer treatment at the American Association for Cancer Research (AACR) annual conference. The company aims to further its research and understanding of mRNA-based approaches and targeted therapies to combat cancer.
March 11, 2024
3 Articles